IRIS : Use of Implantable Defibrillator in High-risk Patients Early After Acute Myocardial Infarction
Acute Myocardial Infarction

About this trial
This is an interventional diagnostic trial for Acute Myocardial Infarction focused on measuring Acute myocardial infarction, Non-sustained ventricular tachycardia, Left ventricular dysfunction, Implantable cardioverter defibrillator, ICD, Risk-stratification
Eligibility Criteria
Inclusion Criteria: acute myocardial infarction (5-31 days) fulfill requirement I and/or II : I first ECG heart rate >= 90 bpm (within day 1-2 post MI) and LVEF <= 40 % (within day 5-31 post-MI) II >= 1 episode of non-sustained ventricular tachycardia >= 150 bpm (on Holter, within 5-31 days post-MI) Exclusion Criteria: Patients with ventricular arrhythmia, requiring clinical therapy, before the index infarction or more than 48 h later Patients with therapy refractory heart failure (NYHA IV) Myocardial infarction older than 31 days First-ECG not available or was recorded more than 48 h after the symptom onset. Patients with indication for CABG operation before inclusion Patients with cerebral organic psycho syndrome Secondary diseases which clearly limit life expectancy Patient with right sided artificial heart valve Patients with poor compliance Patients who are participating in another study Unstable clinical condition Pregnancy No consent from patient
Sites / Locations
- Medtronic Bakken Research Center B.V.